Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

44.20
Delayed Data
As of Jun 23
 +4.11 / +10.25%
Today’s Change
22.45
Today|||52-Week Range
46.81
+43.41%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close40.09
Today’s open40.39
Day’s range39.27 - 46.81
Volume918,047
Average volume (3 months)264,046
Market cap$1.5B
Dividend yield--
Data as of 4:14pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+27.27%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+25.14%
P/E ratio116.3
Price/Sales10.05
Price/Book8.86

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.35+3.47%
ARRYArray Biopharma Inc+0.31+3.54%
EBSEmergent BioSolution...+0.71+2.09%
INVAInnoviva Inc+0.24+1.89%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.15
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts